KYOTO, Japan, Oct. 02, 2017 -- Nidec Corporation (TSE:6594) (OTC US:NJDCY) (the “Company”) today announced the status of the Company’s own share repurchase under its ongoing repurchase plan resolved at a meeting of the Board of Directors held on January 24, 2017, pursuant to Article 459, Paragraph 1, Item 1 of the Company Law of Japan.
Details are as follows:
Details of Share Repurchase
1. Period of own share repurchase: From September 1, 2017 through September 30, 2017
2. Class of shares: Common stock
3. Number of own shares repurchased: 0
4. Total repurchase amount: 0 yen
Note: The above repurchase information has been prepared on the basis of execution date.
Reference
A) The following details were resolved by the Company’s Board of Directors on January 24, 2017:
- Class of shares: Common stock
- Total number of shares that may be repurchased: Up to 5,000,000 shares
(1.69% of total number of shares issued, excluding treasury stock) - Total repurchase amount: Up to 50 billion yen
- Period of repurchase: From January 27, 2017 through January 26, 2018
B) Total number and yen amount of own shares repurchased from January 27, 2017 through September 30, 2017, pursuant to the Board of Directors resolution above:
- Total number of own shares repurchased: 520,000
- Total repurchase amount: 5,138,822,700 yen
Contact:
Masahiro Nagayasu
General Manager
Investor Relations
+81-75-935-6140
[email protected]


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Instagram Outage Disrupts Thousands of U.S. Users 



